Breaking News Instant updates and real-time market news.

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

10:13
06/08/18
06/08
10:13
06/08/18
10:13

The Intersection: Crypto and Wall Street This Week

As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. BITMAIN CEO CONSIDERS IPO: Bitmain Technologies CEO Jihan Wu is pursuing an expansion beyond the crypto market that could eventually lead to an initial public offering, Bloomberg reported Thursday. Wu told Bloomberg that the company booked $2.5B of revenue last year, that he and co-founder Micree Zhan together own a roughly 60% of Bitmain and that he has a smaller holding than Zhan. He added that while he has no specific plans, he's open to a listing in Hong Kong or in an overseas market with U.S.-dollar denominated shares as it would give investors like Sequoia Capital and IDG Capital the chance to cash out. 2. SEC NAMES DIGITAL ASSETS ADVISOR, SAYS CRYPTOCURRENCIES ARE NOT SECURITIES: On Tuesday, the SEC named Valerie Szczepanik associate director of the division of corporation finance and senior advisor for digital assets and innovation for division director Bill Hinman. In this newly-created advisory position, Szczepanik will coordinate efforts across all SEC divisions and offices regarding the application of U.S. securities laws to emerging digital asset technologies and innovations, including initial coin offerings and cryptocurrencies. In a CNBC interview, SEC chairman Jay Clayton said the agency will not be changing the rules for cryptocurrency when it comes to defining securities. He added that the agency is also not adjusting rules for ICOs saying, "If you have an ICO or a stock, and you want to sell it in a private placement, follow the private placement rules. If you want to do any IPO with a token, come see us." Clayton also reiterated that all ICOs constitute securities and that "if it's a security, we're regulating it." 3. COINBASE 'ON TRACK' FOR BROKER-DEALER OPERATIONS, ACQUIRES COMPANIES: In a blog post, Coinbase said it is on track to operate a regulated broker-dealer, pending approval by federal authorities. If approved, Coinbase will soon be capable of offering blockchain-based securities, under the oversight of the SEC and FINRA. Coinbase, which also announced that it acquired Keystone Capital, Venovate Marketplace and Digital Wealth, said securing these licenses will "bring us a step closer to our goal, which is to be the most trusted way for our customers to buy, sell, and use many different types of crypto assets." 4. SEVEN STARS FORMS JV WITH C4DR: Seven Stars Cloud (SSC) announced a joint venture with The Centre for Digital Revolution, or C4DR, to "establish and develop the premier global standards of issuance, sales and distribution of digital assets, with operations out of the UK and mainland Europe." 5. DPW REDUCES DEBT WITH BITCOIN: DPW Holdings (DPW) announced that it has used Bitcoin to reduce the company's debt. DPW incurred new debt recently to support the purchase of Enertec Systems 2001 by another of its subsidiaries Coolisys Technologies. DPW has made a payment of $500,000 towards this new debt thus leveraging the mined Bitcoin through a non-dilutive transaction to shareholders. CRYPTO STOCK PLAYS: Cryptocurrency revenues have been pointed to as reasons to be bullish on Advanced Micro Devices (AMD) and Nvidia (NVDA) in select research. Overstock (OSTK), DPW Holdings, Kodak (KODK), Seven Stars Cloud, Riot Blockchain (RIOT), Pareteum (TEUM) and Social Reality (SRAX) are other stocks that have been touted, or promoted themselves, as a way to play the crypto theme. PRICE ACTION: As of time of writing, bitcoin rose about 2.2% this week to $7,582 in U.S. dollars, according to CoinDesk. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

SSC

Ideanomics

$2.20

0.04 (1.85%)

DPW

DPW Holdings

$0.71

0.0501 (7.59%)

AMD

AMD

$14.92

0.04 (0.27%)

NVDA

Nvidia

$262.59

-0.31 (-0.12%)

OSTK

Overstock.com

$34.90

0.35 (1.01%)

KODK

Kodak

$5.15

-0.05 (-0.96%)

RIOT

Riot Blockchain

$7.46

-0.19 (-2.48%)

TEUM

Pareteum

$2.17

-0.06 (-2.69%)

SRAX

Social Reality

$4.05

-0.03 (-0.74%)

  • 08

    Jun

BTC Bitcoin
$0.00

(0.00%)

11/29/17
STPT
11/29/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $20,000 from $14,000
Standpoint Research analyst Ronnie Moas raised his 2018 price target for bitcoin to $20,000 from $14,000. The current price is around $10,720 and the split-adjusted price is now $12,740 when factoring in Bitcoin Cash, Bitcoin Gold and Bitcoin Diamond, Moas tells investors in an intraday email. There is "no way to justify" gold investments equaling 40 times than that of bitcoin, the analyst argues. He thinks an argument can be made that bitcoin will be equal to gold in 10-15 years. Currently, gold has $7T in investments to bitcoin's $180B, according to Moas.
04/09/18
MSCO
04/09/18
NO CHANGE
Target $88
MSCO
Overweight
PayPal acceptance lead continues to grow, says Morgan Stanley
Morgan Stanley analyst James Faucette said his quarterly tracker shows PayPal maintains its online acceptance lead versus other digital wallets, with acceptance at 79% of the top 500 U.S. Internet retailers, despite investors being "overly concerned" about potential risk to its lead. In the same note, Faucette pointed out that Bitcoin acceptance remained unchanged, with 4 of the top 500 internet retailers he tracks still accepting the cryptocurrency. The analyst, who expects PayPal will continue to benefit from its lead and increasingly serve as a payment-of-choice for non-Amazon merchants, keeps his Overweight rating and $88 price target on the shares.
12/07/17
MSCO
12/07/17
NO CHANGE
MSCO
Morgan Stanley says TD Ameritrade most likely discount broker to embrace bitcoin
Given recent regulatory approval and the upcoming launch of bitcoin futures trading on CME (CME) and CBOE (CBOE), Morgan Stanley analyst Michael Cyprys said he expects discount brokers including E-Trade (ETFC), TD Ameritrade (AMTD) and Ally Financial (ALLY) to offer bitcoin futures trading within the next few months. Among them, he views TD Ameritrade as most likely to embrace bitcoin and lead the way and Charles Schwab (SCHW) as likely to be a latecomer. Cyprys added that he was surprised, given its status as a "challenger brand," that E-Trade has said it will take "a wait-and-see" approach.
12/07/17
STPT
12/07/17
NO CHANGE
STPT
Standpoint raises 2018 bitcoin price target to $28,000 from $20,000
Standpoint Research analyst Ronnie Moas this morning raised his 2018 price target for bitcoin to $28,000 from $20,000. Just over a week ago the analyst raised his 2018 target to $20,000 from $14,000. Moas points out that his longer term public target remains $50,000. He points out in an email that unlike the U.S. dollar, where the government can print money, the supply of bitcoin is capped. We are a couple of years away from being in a situation where hundreds of millions of people around the world are trying to get their hands on a few million bitcoin, Moas contends.
BITCOIN Bitcoin
$0.00

(0.00%)

12/20/17
PIPR
12/20/17
NO CHANGE
Target $46
PIPR
Neutral
Piper ups Metropolitan Bank estimates on cryptocurrency exposure
Piper Jaffray analyst Matthew Breese raised his earnings estimates for Metropolitan Bank by 6% after the company detailed its exposure to a cryptocurrency exchange. Metropolitan's exposure to a cryptocurrency exchange averaged $245M in Q3, or 16% of total deposits, Breese tells investors in a research note. He estimate these items aggregate to 7% of net interest income and 9%-11% of earnings. Yesterday's disclosure is important on both the impact of earnings, the percentage of deposits tied to one customer, and that the bank has exposure to a "controversial industry," Breese tells investors in a research note. The analyst, despite raising his earnings estimates, keeps a Neutral rating on Metropolitan Bank shares with a $46 price target. He views the company's cryptocurrency exposure as a "double-edged sword for the stock." On the one hand, cryptocurrencies represent a "unique source of potential earnings growth" for Metropolitan, Breese writes. On the other, the volatility and potential regulatory concerns surrounding cryptocurrencies may cause some trepidation for traditional depository investors, the analyst adds.
01/08/18
PIPR
01/08/18
NO CHANGE
Target $115
PIPR
Overweight
Piper wonders if Microsoft is better than bitcoin
In a research note titled "Better Than Bitcoin?," Piper Jaffray analyst Alex Zukin updated his investment thesis on Microsoft and formally rolled out estimates for 2019. Azure revenues are still growing close to triple digits and channel checks suggest that the company's pipeline of Office 365 remain robust, Zukin tells investors in a research note. He believes his investment thesis on the shares is resonating and reiterates an Overweight rating on Microsoft with a $115 price target. The software giant closed Friday up $1.08 to $88.19. The analyst calls Azure the "single largest growth opportunity" at Microsoft.
04/18/18
NOMU
04/18/18
NO CHANGE
Target $65
NOMU
Buy
Nomura Instinet ups Square price target to $65 on bitcoin boost
Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) shares to $65 from $64 saying the impact from bitcoin could be meaningful. The stock closed yesterday up $2.10 to $49.13. Opening Square Cash for bitcoin trading earlier this year could drive a "sizable boost" to revenue and profits, driving up to 10% potential upside to adjusted EBITDA guidance, Dolev tells investors in a research note. He sees bitcoin as helping to offset Square's rising investment costs to broaden its international presence. In asking if bitcoin will reshape the future of payments as Square CEO Jack Dorsey often argues, or if it will just be a passing fad, Dolev points out that the company's correlation with the cryptocurrency has been on a downward trend. Square shares are now less correlated with bitcoin than PayPal (PYPL), the payment networks or Alphabet (GOOG, GOOGL), Dolev contends. He maintains a Buy rating on Square.
SSC Ideanomics
$2.20

0.04 (1.85%)

DPW DPW Holdings
$0.71

0.0501 (7.59%)

AMD AMD
$14.92

0.04 (0.27%)

05/18/18
COWN
05/18/18
INITIATION
Target $18
COWN
Outperform
Cowen starts AMD at Outperform, sees potential for taking share from Intel
As reported previously, Cowen analyst Matthew Ramsay initiated AMD (AMD) with an Outperform rating. The analyst believes the company's 7nm products will gain market share versus Intel's (INTC) 10nm silicon in 2019 /2020. Ramsay has a $18 price target on AMD shares.
05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
COWN
05/17/18
INITIATION
Target $18
COWN
Outperform
AMD initiated with an Outperform at Cowen
Cowen initiated AMD with an Outperform and $18 price target.
06/01/18
STFL
06/01/18
NO CHANGE
Target $17
STFL
Buy
AMD price target raised to $17 from $14 at Stifel
Stifel analyst Kevin Cassidy increased his estimates for AMD following his review of the processor market, stating that the company continuing to meet its product introduction milestones is increasing their customers' confidence in adopting AMD CPUs and GPUs. The analyst, who believes AMD's EPYC server CPU is winning server designs, raised his price target on AMD shares to $17 from $14 and keeps a Buy rating on the stock.
NVDA Nvidia
$262.59

-0.31 (-0.12%)

05/17/18
COWN
05/17/18
INITIATION
Target $325
COWN
Outperform
Nvidia initiated with an Outperform at Cowen
Cowen initiated Nvidia with an Outperform and $325 price target.
05/18/18
COWN
05/18/18
INITIATION
Target $325
COWN
Outperform
Cowen says Nvidia transformation complete, starts at Outperform
As reported previously, Cowen analyst Matthew Ramsay initiated Nvidia with an Outperform rating as he believes the company's transformation from a PC-leveraged GPU supplier to a diverse parallel computing company is complete. Nvidia now has target markets of gaming, datacenter, professional visualization and autonomous driving growth, said Ramsay, who has a $325 price target on the shares.
05/30/18
RSBL
05/30/18
NO CHANGE
RSBL
Smartphone supply chain may have some upside in Q2, says Rosenblatt
Rosenblatt analyst Jun Zhang believes there may be some upside for the smartphone supply chain during Q2 despite conservative guidance from many component providers given the early ramp of production for a new iPhone from Apple (AAPL) at the beginning of August. He also believes Chinese OEMs recently increased their component orders as previous forecasts were too pessimistic and sell through of new smartphone models is getting slightly better. Publicly traded semiconductor makers include Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN).
06/06/18
MSCO
06/06/18
NO CHANGE
MSCO
Overweight
Nvidia comments on consumer gaming GPU look like a setback, says Morgan Stanley
Morgan Stanley analyst Joseph Moore noted that Nvidia CEO Jensen Huang said it will be "a long time" before the next generation consumer graphics chip for gamers is seen. While the phrase "a long time" is vague and he seeks further color from management, Moore said this appears to be a tactical setback as the product cycle was key to his growth assumptions in the October and January quarters. However, he still sees pent up demand for Pascal gaming products and notes the strong data center ramp is unaffected. Moore keeps an Overweight rating on Nvidia shares.
OSTK Overstock.com
$34.90

0.35 (1.01%)

04/03/18
DADA
04/03/18
NO CHANGE
Target $100
DADA
Buy
Overstock's e-commerce and Medici Ventures still offer value, says DA Davidson
DA Davidson analyst Tom Forte keeps his Buy rating and $100 price target on Overstock.com, saying the company's legacy e-commerce business and its cryptocurrency exposure through the Medici Ventures subsidiary offer "significant value". Forte believes the e-commerce business alone could be valued at $48 per share on speculation of a strategic tie-up as he anticipates a "material improvement" in sales trends in Q1. The analyst also sees the completion of the tZERO ICO as a significant potential near-term catalyst.
04/03/18
PIPR
04/03/18
NO CHANGE
Target $92
PIPR
Overweight
Wayfair valuation becoming attractive, says Piper Jaffray
Piper Jaffray analyst Peter Keith lowered his price target for Wayfair to $92 from $112 but says the valuation is becoming attractive following the recent selloff. The analyst reiterates an Overweight rating on the shares. The pending Supreme Court case on e-commerce sales tax should be a relative non-event for Wayfair, Keith tells investors in a research note. Further, the analyst believes recent comments by Overstock.com (OSTK) to gain share through increased spending "appears likely easier said than done." Keith thinks Way-day - Wayfair's Prime-day equivalent - will run during Q2 and likely serve as a near-term positive.
03/26/18
LOOP
03/26/18
NO CHANGE
Target $87
LOOP
Buy
Wayfair pullback is a 'buying opportunity', says Loop Capital
Loop Capital analyst Laura Champine views the recent pullback in the price of Wayfair (W) stock as a buying opportunity, keeping her Buy rating and $87 price target. The analyst notes that investors sold on worries about heightened competition underscored by comments from Overstock (OSTK) on March 15th about spending more on advertising, adding she does not expected Overstock's home furnishing budget ramp-up to be sufficiently significant to affect Wayfair. Champine believes that Wayfair's "early mover advantage" in a niche category will prove sustainable, along with its "best-in-class selection" and delivery network as "key competitive advantages".
05/03/18
DADA
05/03/18
NO CHANGE
Target $60
DADA
Underperform
Wayfair price target raised to $60 from $55 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Wayfair (W) to $60 after its Q1 results, saying the company outperformed on sales and EBITDA while its outlook for FY18 was also better than initially projected. The analyst keeps his Underperform rating however, noting continued competitive pressure from Overstock (OSTK) and attributing the stronger Q1 in part to Way Day discounting / pulled demand.
KODK Kodak
$5.15

-0.05 (-0.96%)

RIOT Riot Blockchain
$7.46

-0.19 (-2.48%)

05/11/18
HCWC
05/11/18
INITIATION
Target $9
HCWC
Buy
Riot Blockchain initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Kevin Dede initiated coverage of Riot Blockchain with a Buy rating and $9 price target. The shares closed yesterday down 21c to $7.23. The analyst, who calls his price target "conservative," see an attractiveness in a "nationally available, easy-to-use digital currency platform that settles trades almost immediately bolstered by an in-house digital currency mining operation." Riot now operates an industrial-class bitcoin mining operation in Oklahoma City running more than 4,000 mining machines and is expected to have 8,000 working by the end of May, Dede tells investors in a research note. He believes the "beauty" in Riot Blockchain's mining operation is that it creates a digital currency inventory, providing liquidity for trading, as well as capital on the order of $40,000-$50,000 gross per day at high margin levels. Dede thinks Riot's advantages in developing a user-friendly digital currency exchange are underappreciated by the investment community.
05/11/18
05/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) initiated with an Outperform at Bernstein. 2. Dexcom (DXCM) initiated with a Buy at BofA/Merrill. 3. Riot Blockchain (RIOT) initiated with a Buy at H.C. Wainwright. 4. American Eagle (AEO) initiated with an Outperform at Wedbush, while Abercrombie & Fitch (ANF) , Express (EXPR) initiated with a Neutral at Wedbush, and Lululemon (lulu) were initiated with a Neutral. 5. Lincoln National (LNC) reinstated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/18
HCWC
05/18/18
NO CHANGE
Target $10
HCWC
Buy
Riot Blockchain price target raised to $10 from $9 at H.C. Wainwright
H.C. Wainwright analyst Kevin Dede raised his price target for Riot Blockchain to $10 saying last night's quarterly filing itself "may perhaps bear greater intrinsic value than the figures it contains." He notes the company's Mining operations delivered $900,000 for the quarter, which he suspect compares to roughly $200,000 mined in the Q4 of last year during which mining operations commenced. Dede keeps a Buy rating on Riot Blockchain shares.
TEUM Pareteum
$2.17

-0.06 (-2.69%)

SRAX Social Reality
$4.05

-0.03 (-0.74%)

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

, GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

12:59
06/15/19
06/15
12:59
06/15/19
12:59
Periodicals
Facebook, JPMorgan chiefs among Best CEOs of 2019, Barron's says »

Separated into three…

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

FB

Facebook

$181.35

3.88 (2.19%)

MCD

McDonald's

$205.33

0.85 (0.42%)

JPM

JPMorgan

$109.84

0.26 (0.24%)

BAC

Bank of America

$28.03

0.09 (0.32%)

BLK

BlackRock

$446.96

-1.29 (-0.29%)

BX

Blackstone

$44.13

0.17 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 27

    Oct

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

, AAPL

Apple

$192.84

-1.93 (-0.99%)

07:17
06/15/19
06/15
07:17
06/15/19
07:17
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

AAPL

Apple

$192.84

-1.93 (-0.99%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

UTX

United Technologies

$125.30

0.45 (0.36%)

RTN

Raytheon

$177.38

0.195 (0.11%)

CGC

Canopy Growth

$41.15

-0.64 (-1.53%)

TLRY

Tilray

$38.96

-1.78 (-4.37%)

APHA

Aphria

$6.80

-0.15 (-2.16%)

ACB

Aurora Cannabis

$7.56

(0.00%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$15.43

-0.92 (-5.63%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$1.28

0.4201 (48.85%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

ZYNE

Zynerba

$13.03

-0.54 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 25

    Jun

  • 09

    Jul

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, ABMD

Abiomed

$250.96

-4.58 (-1.79%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
International League of Dermatological Societies to hold a conference »

24th World Congress of…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

ABMD

Abiomed

$250.96

-4.58 (-1.79%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

JNJ

Johnson & Johnson

$140.08

-0.63 (-0.45%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PG

Procter & Gamble

$111.20

0.28 (0.25%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

UL

Unilever; also tag UN

$62.61

-0.07 (-0.11%)

UN

Unilever; also tag UL

$61.30

-0.13 (-0.21%)

INCY

Incyte

$77.76

1.385 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 26

    Jun

  • 27

    Jun

  • 16

    Jul

  • 25

    Jul

  • 30

    Jul

  • 28

    Aug

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

, GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Congress of Rheumatology to hold a conference »

EULAR 2019 will be held…

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

PFE

Pfizer

$42.75

0.24 (0.56%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

RHHBY

Roche

$0.00

(0.00%)

BIIB

Biogen

$227.67

-3.57 (-1.54%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

REGN

Regeneron

$305.19

-2.235 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 25

    Jul

  • 30

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABT

Abbott

$82.25

-0.03 (-0.04%)

, AMGN

Amgen

$176.09

-0.74 (-0.42%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
Society for Vascular Surgery to hold annual meeting »

SVS Annual Meeting 2019…

ABT

Abbott

$82.25

-0.03 (-0.04%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

BSX

Boston Scientific

$40.41

-0.26 (-0.64%)

PFE

Pfizer

$42.75

0.24 (0.56%)

CRY

CryoLife

$29.13

-0.13 (-0.44%)

EW

Edwards Lifesciences

$184.00

-0.63 (-0.34%)

ELGX

Endologix

$7.61

0.2 (2.70%)

IAC

IAC

$228.41

-2.63 (-1.14%)

HCA

HCA Healthcare

$126.64

-0.76 (-0.60%)

LMAT

LeMaitre

$26.04

-0.44 (-1.66%)

ORGO

Organogenesis

$7.39

0.02 (0.27%)

OSIR

Osiris

$0.00

(0.00%)

PEN

Penumbra

$166.75

2.93 (1.79%)

SWAV

ShockWave Medical

$58.27

-0.99 (-1.67%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

  • 09

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 16

    Sep

  • 25

    Sep

  • 13

    Nov

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

CNC

Centene

$53.52

-0.26 (-0.48%)

, WCG

WellCare

$287.16

0.145 (0.05%)

18:45
06/14/19
06/14
18:45
06/14/19
18:45
Hot Stocks
Centene CEO: Medicare for all will not work »

In an interview on…

CNC

Centene

$53.52

-0.26 (-0.48%)

WCG

WellCare

$287.16

0.145 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

HMC

Honda

$25.34

-0.405 (-1.57%)

18:24
06/14/19
06/14
18:24
06/14/19
18:24
Hot Stocks
Honda recalls all 2016-2019 model year Pioneer vehicles »

Honda is conducting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$111.28

1.42 (1.29%)

18:22
06/14/19
06/14
18:22
06/14/19
18:22
Hot Stocks
RH CEO: We think our stock is massively undervalued »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$37.54

-0.35 (-0.92%)

, S

Sprint

$7.01

0.2 (2.94%)

18:08
06/14/19
06/14
18:08
06/14/19
18:08
Periodicals
Dish leads bidding for Sprint, T-Mobile assets, WSJ reports »

Dish Network (DISH) is…

DISH

Dish

$37.54

-0.35 (-0.92%)

S

Sprint

$7.01

0.2 (2.94%)

TMUS

T-Mobile

$74.90

0.44 (0.59%)

CHTR

Charter

$392.20

2.76 (0.71%)

ATUS

Altice USA

$23.82

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$32.69

-0.39 (-1.18%)

17:31
06/14/19
06/14
17:31
06/14/19
17:31
Periodicals
American Air asks court to end 'devastating' work slowdown, Bloomberg says »

American Airlines urged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$150.43

-3.38 (-2.20%)

17:16
06/14/19
06/14
17:16
06/14/19
17:16
Hot Stocks
RBC Bearings CEO sells over 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$1.25

(0.00%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
FTE Networks granted financial viability exception by NYSE regulation »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$347.19

-1.54 (-0.44%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
Boeing awarded Air Force contract modification, increases ceiling by $6.53B »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

MDR

McDermott

$7.60

-0.12 (-1.55%)

17:11
06/14/19
06/14
17:11
06/14/19
17:11
Hot Stocks
Chatterjee Fund Management reports 5.6% passive stake in McDermott »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$50.74

0.28 (0.55%)

17:09
06/14/19
06/14
17:09
06/14/19
17:09
Hot Stocks
Papa John's dismisses KPMG as auditors, hires Ernst & Young »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 13

    Nov

EPZM

Epizyme

$11.62

-0.36 (-3.01%)

16:55
06/14/19
06/14
16:55
06/14/19
16:55
Conference/Events
Epizyme to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

CACI

CACI

$202.80

-1.205 (-0.59%)

16:54
06/14/19
06/14
16:54
06/14/19
16:54
Conference/Events
CACI to hold a conference call »

Management holds a fiscal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HCR

Hi-Crush Inc.

$2.84

0.115 (4.22%)

16:53
06/14/19
06/14
16:53
06/14/19
16:53
Syndicate
Hi-Crush Inc files $1B mixed securities shelf »

The company also files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$0.63

-0.0381 (-5.70%)

16:51
06/14/19
06/14
16:51
06/14/19
16:51
Earnings
Seanergy Marine reports Q1 EPS ($3.23), two estimates ($2.85) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.